Additionally, BP/IncellDX and Amarex (the two prim
Post# of 148170
Like misiu noted, I'm guessing cancer enrollment has slowed simply due to travel restrictions and even more so due to the risk of these highly immune comprised individuals. So those previously enrolled are still receiving treatment (hopefully) and data being sent to IncellDX and Amarex, but put on the 'as soon as I can get to it' shelf with CV-19. Just my guesses.